HI SB2268 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on January 19 2018 - 25% progression, died in committee
Action: 2018-01-22 - Referred to CPH, JDC.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 19 2018 - 25% progression, died in committee
Action: 2018-01-22 - Referred to CPH, JDC.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Beginning January 1, 2019, allows manufacturers of investigational drugs, biological products, or devices to make available such drugs, products, or devices to terminally ill patients under certain conditions.
Title
Relating To Access To Treatment For Terminally Ill Patients.
Sponsors
| Sen. Josh Green [D] | Sen. Mike Gabbard [D] | Sen. Russell Ruderman [D] | Sen. Glenn Wakai [D] |
| Sen. Stanley Chang [D] | Sen. Brickwood Galuteria [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-01-22 | Senate | Referred to CPH, JDC. |
| 2018-01-22 | Senate | Passed First Reading. |
| 2018-01-19 | Senate | Introduced. |
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=2268&year=2018 |
| Text | https://www.capitol.hawaii.gov/session2018/bills/SB2268_.HTM |
